Welcome to our website!
This is Mi Won SOHN, CEO of MTHERA PHARMA.
MTHERA PHARMA was established in February 2020.
By collaborating with world renowned scholars of Korea,
we developed expertise in multi-component and
multi-targeting (MCMT) approach and cutting-edge CMC technology.
We strive to be a more global pharmaceutical R&D company
by pursuing health and happiness of mankind
through development of new medicine for chronic diseases.
We look forward to your support and attention.